Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Remifentanil In Icu @ Mri

on

  • 3,299 views

Implementation of Remifentanil

Implementation of Remifentanil
Intensive Care Sedation

Statistics

Views

Total Views
3,299
Slideshare-icon Views on SlideShare
3,292
Embed Views
7

Actions

Likes
2
Downloads
97
Comments
0

1 Embed 7

http://www.slideshare.net 7

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Achieving a balance
  • Redist t ½ for alf = 36 min but elim t ½ 375 min

Remifentanil In Icu @ Mri Remifentanil In Icu @ Mri Presentation Transcript

  • Remifentanil in ICU @ Manchester Royal Infirmary Daniel Conway Consultant in Critical Care Manchester Royal Infirmary
  • Sedation & Analgesia on ICU – an uncomfortable paradigm Traditional analgesics will accumulate over time + metabolites Painful procedures, general discomfort should be treated Excess sedation extends length of stay and may worsen PTSD symptoms Inadequate sedation or analgesia may worsen PTSD symptoms
  • Moving Away from Sedation
    • Early detection of neurological problems
      • Stroke / bleeds / hypoxia
      • Delirium
    • Early extubation before tracheostomy
    • ‘ Fast track’ major surgery with regional analgesia
    • Withdrawal and weaning
    • Reduced ICU length of stay
  • Shorter Acting Agents
    • Propofol Carsson, Kress Crit Care Med 2006
      • Rapid offset due to redistribution
      • Hypotension & ? acidosis
    • Alfentanil
      • Minimal metabolites
      • Less accumulation than morphine & fentanyl
    • Remifentanil
      • Esterase metabolism
      • Rapid offset
  • Remifentanil Pharmacokinetics
    • Rapid offset 6-8 minutes
    • Independent of Renal / Hepatic Function
    • Independent of BMI
    • Titratable
      • Analgesia
      • Respiratory depression
  • Stable context sensitive t 1/2 Egan Anaesthesiology 1993;79: 881-92
  • Hypnotic or Narcotic ????
  • Hypnotic or Narcotic ????
    • BDZ & Propofol
    • GABA agonist
    • Anxiolytic / amnesic
    • Prolong Ventilation
    • Cause delirium
    • Contribute to long term cognitive dysfunction
    • Opioids & α 2 agonists
    • Hypotensive
    • Analgesic
    • Withdrawal phenomena
    • Less delirium ?
    • Long term cognition?
  • Remifentanil on ICU?
    • Neurological examination
    • Analgesia for procedures
    • Patients with hepatic and renal impairment
    • Fast track extubations
      • Surgical
      • Short stay medical eg overdose
    • All Patients who require analgesia ????
  • Remifentanil on general ICU Breen D, Karabinis A et al Crit Care 2005
    • Open Label RCT remi v midaz/ morph fent
    • 105 patients in 15 ICU’s
    • Exclusions: NMBA, surgery, epidural, sensit
    • Remi dose 0.2 mcg/kg/min
    • Time to extubation, LOS on ICU
    • SAS, Pain Index, mAP, 6 day follow up
  • Remifentanil on ICU Breen D, Karabinis A et al Crit Care 2005
    • ↓ Midaz dose
    • Similar Sedation & Pain scores
    • ↑ Vomiting with remi
    • Non-sig ↓ in ICU LOS with remi
  • Remifentanil on ICU Breen D, Karabinis A et al Crit Care 2005
    • Re-intubations 7/25 remi v 2/12 hypnotic
  • Head Injury
  • Remifentanil With Head Injury Karabinis A et al Crit Care (2004)
    • Analgesia based v hypnotic regime
      • Remifentanil v Fentanyl v Morphine
      • Midazolam or propofol also used
      • Remifentanil 15mcg/kg/hr (0.25mcg/kg/min)
    • 161 patients in 17 hospitals open label RCT
    • LOS, SAS, mAP, HR, ICP and CPP
    • Time to extubation
  • Remifentanil With Head Injury Karabinis   A et al Crit Care 2004
    • Similar mAP HR
    • No difference in ICP or CPP
    • ↓ Propofol requirement
    • Optimal sedation
      • 95% of time – remi
      • 99% of time - fentanyl
  • Improved time to neurological assessment with remi Karabinis   A et al Crit Care 2004
  • Adverse Events Karabinis   A Crit Care 2004
    • bradycardia,
    • cerebral infarction
    • oedema
    • Hypotension
    • intracranial haemorrhage
  • Hypnotic v Analgesic sedation Park, Lane B J Anaes 2007
    • 12 wk hypnotic based drugs
    • 12 wk analgesics (predominantly remi)
    • All ventilated patients
    • Excluded if NMBA
    • Looked at Mortality / LOS / dreams memory
    • Looked at drug use
  • Hypnotic v Analgesic sedation Park, Lane B J Anaes 2007
    • 111 Hyp and 96 Ana patients
    • Age 58 v 56
    • APACHE II 16.5 v 18.1
    • ICU Mortality 23% v 26%
    • Hosp Mortality 31% v 35%
    • Time on Vent 37h v 71h n/s
    • LoS ICU 67 v 118
  • Hypnosis v Analgesia Park, Lane BJA 2007
    • 37% of patients could be managed with remifentanil alone
    • 40-50% experienced dreams or hallucinations which most found unpleasant
    • 5 accidental extubations in analgesic (3 on remi) vs 2 in hypnotic
    • Remi reduced propofol requirements
  • Remifentanil on ICU: Tolerance, Side Effects and Withdrawal
    • It’s an opioid !
    • Tolerance with prolonged infusion Vinik An Anal 98
    • Side Effects
      • Bradycardia and Hypotension
      • Nausea/Vomiting/Ileus
      • Respiratory Depression
    • Withdrawal phenomena Apitzsch Anaesthetist 99
  • Remifentanil and Glycine Bonnet MP, Benhamou D et al Int Care Med 07
    • Glycine: inhibitory neurotransmitter
    • Remi powder has 3mg glycine for each mg remi
    • 72 hour infusion, toxic levels NOT reached
    • Correlation between remi rate and glycine levels
    • Glycine accumulation with ↓ Creat CL
  • Remifentanil in Manchester
  • Implementing Remifentanil @ MRI
    • Consultants Agree Patient Group
    • Pharmacist produces guidelines
    • Nurse Education Practitioner
    • Regular Meetings
    • Audit use month on month
    • Guidelines modified
  • Remifentanil on ICU @ MRI
    • Indication
      • Analgesia and sedation
      • Head injury / early extubation
      • Hepatic and Renal Impairment
    • Contra-indications
      • Spont Vent or NIV or paralysed
      • Opioid intolerance
      • Bolus administration
  • Remifentanil Guideline MRI
    • Duration 3 Days max
    • Constitution
      • 100 μ g/ml in 50 ml N/Sal or 5%Dex
    • Withdrawal
      • Stop infusion if no further analgesia
      • Reduce by 25% every 15min if alt analgesic
  • Start Anxiolysis propofol or midazolam Patient needs analgesia/sedation Patient needs further analgesia/sedation Not For Remifentanil Patient paralysed/ encephalopathic 6mcg/kg/h Remifentanil Increase Remifentanil 1.5 mcg/kg/h At 12mcg/kg/h Remifentanil Patient still needs analgesia/sedation If remains in pain increase remifentanil 15mcg/kg/h + propofol or midazolam AND D/W Doctor
  • Case Study 1
    • 72 yr man, alcoholic liver disease
    • Urinary obstruction and sepsis
    • Acute on chronic renal failure
    • Agitated & Hypoxic ?? needs CVVH,
    • Ventilated 40 hours
    • Renal function improves without CVVH
    • Remifentanil and propofol stopped
    • Extubated & sent to ward next day
  • Case Study 2
    • 38 yr woman, Tracheal reconstruction surgery. Surgeons want sedated 48hrs
    • Remifentanil peri-op
    • Taken back to theatre day 1
    • Remifentanil & propofol continued 48 h
    • Controlled titration of remifentanil until patient awake and not agitated / coughing
  • Summary: Remifentanil on ICU
    • Short acting opioid for analgesia & sedation
    • Useful in renal patients
    • May facilitate early extubation
    • Take care when stopping infusions
    • Staff training was essential
    • Start Pain Scores
  • nfusion rates of remifentanil by body weight using a 100μg/mL solution 18.0 14.4 10.8 7.2 120 17.3 13.8 10.4 6.9 115 16.5 13.2 9.9 6.6 110 15.8 12.6 9.5 6.3 105 15.0 12.0 9.0 6.0 100 14.3 11.4 8.6 5.7 95 13.5 10.8 8.1 5.4 90 12.8 10.2 7.7 5.1 85 12.0 9.6 7.2 4.8 80 11.0 9.0 6.8 4.5 75 10.5 8.4 6.3 4.2 70 9.8 7.8 5.9 3.9 65 9.0 7.2 5.4 3.6 60 8.3 6.6 5.0 3.3 55 7.5 6.0 4.5 3.0 50 6.8 5.4 4.1 2.7 45 6.0 4.8 3.6 2.4 40 15 μg/kg/h (mL/h) 12 μg/kg/h (mL/h) 9 μg/kg/h (mL/h) 6 μg/kg/h (mL/h) Body weight (kg)
    • Key messages   In neurotrauma patients requiring intensive care for up to 5 days, analgesia-based sedation using remifentanil compared with a standard hypnotic-based technique provided the following:
    • • a significant reduction in the mean time taken to wake the patient for assessment of neurological function;• a significantly reduced mean between-patient variability in the time to wake-up, making the performance of this assessment more predictable;• a significantly shorter time to extubation than with a hypnotic-based regimen using morphine as the analgesic;• no clinical differences in pain and sedation scores;• a trend towards reduced dosing with propofol;• comparable haemodynamic and cerebral haemodynamic stability;• higher user satisfaction rating by physicians and nurses;• a similar safety profile.